Potential Myocardial Iron Content Evaluation by Magnetic Resonance Imaging in Thalassemia Major Patients Treated with Deferoxamine or Deferiprone During a Randomized Multicenter Prospective Clinical Study-Reference-Cited by-同舟云学术

Potential Myocardial Iron Content Evaluation by Magnetic Resonance Imaging in Thalassemia Major Patients Treated with Deferoxamine or Deferiprone During a Randomized Multicenter Prospective Clinical Study

Published:2003-01 Issue:2 Volume:27 Page:63-76
ISSN:0363-0269
Container-title:Hemoglobin
language:en
Short-container-title:Hemoglobin

Author:

Galia Massimo,Midiri Massimo,Bartolotta Vincenzo,Morabito Alberto,Rizzo Michele,Mangiagli Antonino,Malizia Roberto,Borsellino Zelia,Capra Marcello,D'Ascola Domenico G.,Magnano Carmelo,Gerardi Calogera,Rigano Paolo,Maggio Aurelio,Galia Massimo,Midiri Massimo,Bartolotta Vincenzo,Morabito Alberto,Rizzo Michele,Mangiagli Antonino,Malizia Roberto,Borsellino Zelia,Capra Marcello,D'Ascola Domenico G.,Magnano Carmelo,Gerardi Calogera,Rigano Paolo,Maggio Aurelio

Publisher

Informa UK Limited

Subject

Biochemistry, medical,Clinical Biochemistry,Genetics(clinical),Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1081/HEM-120021538

Reference39 articles.

1. Survival in Medically Treated Patients with Homozygous β-Thalassemia

2. Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia Major

3. Treatment of Cooley's anemia [see comments]

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox;PLOS ONE;2019-02-27

2. Efficacy and safety of iron chelators in thalassemia and sickle cell disease: a multiple treatment comparison network meta-analysis and trial sequential analysis;Expert Review of Clinical Pharmacology;2018-05-18

3. Chelation therapy in cardiovascular disease: an update;Expert Review of Clinical Pharmacology;2017-06-19

4. A Systematic Review and Meta-Analysis of Deferiprone Monotherapy and in Combination with Deferoxamine for Reduction of Iron Overload in Chronically Transfused Patients with β-Thalassemia;Hemoglobin;2014-10-13

5. Comparative Efficacy and Safety of Deferoxamine, Deferiprone and Deferasirox on Severe Thalassemia: A Meta-Analysis of 16 Randomized Controlled Trials;PLoS ONE;2013-12-23